Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Jul 12;131(2):153–164. doi: 10.1111/bju.15836

International Alliance of Urolithiasis guideline on retrograde intrarenal surgery

Guohua Zeng 1,, Olivier Traxer 2, Wen Zhong 1, Palle Osther 3, Margaret S Pearle 4, Glenn M Preminger 5, Giorgio Mazzon 6, Christian Seitz 7, Petrisor Geavlete 8,9, Cristian Fiori 10, Khurshid R Ghani 11, Ben H Chew 12, Kah Ann Git 13, Fabio Carvalho Vicentini 14, Athanasios Papatsoris 15, Marianne Brehmer 16, Juan Lopez Martinez 17, Jiwen Cheng 18, Fan Cheng 19, Xiaofeng Gao 20, Nariman Gadzhiev 21, Amelia Pietropaolo 22, Silvia Proietti 23, Zhangqun Ye 24, Kemal Sarica 25,
PMCID: PMC10084014  PMID: 35733358

Abstract

Objectives

To set out the second in a series of guidelines on the treatment of urolithiasis by the International Alliance of Urolithiasis that concerns retrograde intrarenal surgery (RIRS), with the aim of providing a clinical framework for urologists performing RIRS.

Materials and Methods

After a comprehensive search of RIRS‐related literature published between 1 January 1964 and 1 October 2021 from the PubMed database, systematic review and assessment were performed to inform a series of recommendations, which were graded using modified GRADE methodology. Additionally, quality of evidence was classified using a modification of the Oxford Centre for Evidence‐Based Medicine Levels of Evidence system. Finally, related comments were provided.

Results

A total of 36 recommendations were developed and graded that covered the following topics: indications and contraindications; preoperative imaging; preoperative ureteric stenting; preoperative medications; peri‐operative antibiotics; management of antithrombotic therapy; anaesthesia; patient positioning; equipment; lithotripsy; exit strategy; and complications.

Conclusion

The series of recommendations regarding RIRS, along with the related commentary and supporting documentation, offered here should help provide safe and effective performance of RIRS.

Keywords: guideline, urolithiasis, treatment, retrograde intrarenal surgery, RIRS, flexible ureteroscopy, #KidneyStones, #UroStone, #EndoUrology

Introduction

Urolithiasis is one of the most common benign urological conditions, and as such, guidelines regarding surgical treatment are advisable in order to promote evidence‐based treatment decisions and reduce variability in practice. A number of international associations, including the AUA, the European Urological Association and the Chinese Urological Association and others, have proposed guidelines on urolithiasis [1, 2], but their focus is primarily on providing an overview of the principles of stone management based on outcomes reported in the literature and expert opinion, rather than on the technical details of the procedure.

Retrograde intrarenal surgery (RIRS) is a long‐established treatment method for the management of upper urinary tract stones [3]. However, complications and non‐standard application hinder the widespread application of this technique. With the aim of rendering RIRS a safe and efficient treatment method, and therefore more widely utilized, evidence‐based step‐by‐step procedure guidelines are urgently needed in clinical practice. The International Alliance of Urolithiasis (IAU) has undertaken to develop a series of urolithiasis management guidelines, primarily involving surgical management. The first IAU series guideline, on percutaneous nephrolithotomy (PCNL), has been published [4], and the present guideline on RIRS is the second in this series. The aim of this guideline was to provide a clinical framework for surgeons performing RIRS, including peri‐operative evaluation, intra‐operative procedural recommendations and follow‐up strategies.

The IAU Guideline Panel on RIRS comprises a group of international experts in stone disease, with particular expertise in RIRS. No members of this panel declared a conflict of interest with regard to these recommendations. The panel and the released guidelines will be updated every 2 years in future.

Methods

Data Identification

For the IAU guideline on RIRS, all recommendations were developed after systematic review and assessment of the literature. A comprehensive literature search for studies covering all aspects of RIRS and published between 1 January 1964 and 1 October 2021 was performed using the PubMed database. Key terms included ‘retrograde intrarenal surgery’, ‘RIRS’, ‘flexible ureteroscopy’,’fURS’ and ‘ureteroscopy’.

Grading of Recommendations and Level of Evidence

A modified GRADE (Grading of Recommendations, Assessment, Development and Evaluations) methodology was used to grade the recommendations (GR) [5]. According to this system, the body of evidence was assigned a rating of A (high‐quality evidence; high certainty), B (moderate‐quality evidence; moderate certainty), or C (low‐quality evidence; low certainty) according to the evidence that was reviewed.

The level of evidence (LE) was graded using a classification system modified from the Oxford Centre for Evidence‐Based Medicine Levels of Evidence system [6]. Level 1 was the highest and Level 5 the lowest, with these levels assigned according to the details and homogeneity of the studies.

Guideline

Indications

  • Intrarenal or proximal ureteric stones less than 20 mm in diameter (LE:1, GR:A).

  • Intrarenal or proximal ureteric stones larger than 20 mm when PCNL is ill‐advised or contraindicated (LE:2, GR:B).

Retrograde intrarenal surgery and shock wave lithotripsy are both regarded as first‐line treatment options for intrarenal or proximal ureteric stones <20 mm [1, 2, 7, 8, 9, 10, 11]. However, RIRS is associated with a higher single‐procedure success rate and a lower re‐treatment rate compared to shock wave lithotripsy [8, 9, 10, 11].

Lower pole stones can be challenging for RIRS in the case of narrow lower pole infundibular, acute infundibulopelvic angle or other associated renal anatomical abnormalities [8, 9, 10, 11].

Retrograde intrarenal surgery is usually considered to be part of endoscopic combined intrarenal surgery (ECIRS) for complex stones larger than 2 cm when PCNL monotherapy is not feasible [12]. RIRS monotherapy may require staged procedures to treat large stone burdens [13, 14, 15, 16].

Contraindications

  • Acute symptomatic UTI (LE:1, GR:A).

  • Patient unfit for general or regional anaesthesia (LE:4, GR:A).

For patients with acute symptomatic bacteriuria, if fever or septic shock is noted, with the exception of antibiotic treatment, a nephrostomy tube or JJ stent are required for a period of drainage before lithotripsy, otherwise RIRS in patients with acute symptomatic bacteriuria might bring about life‐threatening sequelae,such as urosepsis [17, 18, 19].

General or regional anaesthesia is generally required for RIRS [20, 21]; therefore, RIRS should not be administrated in patients with anaesthetic contraindications.

Preoperative Stenting

  • Routine ureteric stenting prior to RIRS is not recommended (LE:1, GR:A).

  • In case of failed access to the upper urinary tract during RIRS, placement of a stent is advisable to allow passive ureteric dilatation and subsequent attempt at second RIRS (LE:1, GR:A).

Although there is little evidence that preoperative stenting improves stone‐free rates (SFRs), several studies have shown that preoperative stenting for a duration of 1–2 weeks may allow passive dilatation of the ureter, increasing the success of ureteric access sheath (UAS) placement and reducing the risk of high‐grade ureteric injuries [22, 23, 24, 25, 26, 27, 28, 29, 30, 31]. Additionally, preoperative stenting may be necessary to drain an obstructed and/or infected renal unit prior to RIRS [32]. However, routine ureteric stenting in all patients prior to RIRS is not recommended because of the additional cost and risk of a second anaesthetic procedure, additional radiation exposure and side effects from prolonged stenting [32].

Preoperative Imaging

  • Low‐dose non‐contrast CT (NCCT) is recommended prior to RIRS in cases where other radiological evaluation means (plain abdominal film of kidney, ureter and bladder [KUB] and sonography) fail to give adequate information (LE:3, GR:B).

  • Contrast‐enhanced CT and intravenous urography with excretory phases is recommended when renal pelvic‐calyceal anatomy requires a detailed assessment (LE:3, GR:C).

Low‐dose NCCT is the most sensitive imaging method to diagnose the urinary calculi, with decreased radiation exposure [33, 34, 35, 36, 37, 38, 39]. It allows accurate determination of stone size and volume, stone multiplicity, stone density and state of the renal parenchyma since other means of radiological evaluation (KUB and sonography) fail to give adequate information on these variables. Contrast‐enhanced CT and intravenous urography with excretory phases is recommended when the renal pelvic‐calyceal anatomy, especially the renal collecting system anatomy, requires detailed assessment. For example, they can be used to assess infundibulopelvic angle, infundibular width and infundibular length, which are important risk factors used to predict SFR after RIRS [40, 41]. Three‐dimensional helical CT is sometimes required for complicated cases [42].

Preoperative Medications

Use of α‐Blockers

  • The short‐term administration of oral alpha blockers may be considered prior to RIRS (LE:2, GR:A).

Limited evidence suggests that 3–7 days of preoperative oral α‐blockers may facilitate successful UAS insertion in patients without pre‐stenting and protect against potential ureteric wall injury during UAS insertion [43, 44, 45, 46].

Antibiotics

  • Urine analysis and urine culture should be performed prior to RIRS (LE:1, GR:A).

  • In patients with a positive preoperative midstream urine culture, antibiotic treatment should be administered according to culture antibiogram test findings (LE:1, GR:A).

  • In patients with a negative midstream urine culture, a single dose of antibiotic prophylaxis according to the prevalent local antibiotic resistance patterns should be administered before RIRS (LE:1, GR:A).

Currently, despite universal consensus on the utilization of antibiotic prophylaxis and treatment of UTI before RIRS as presented in the above statements [47, 48, 49], the optimal type and duration of pre‐procedure antibiotic administration remains uncertain due to lack of high‐level evidence. Furthermore, there is ongoing controversy regarding positive urine analysis for leukocytes and/or nitrites, asymptomatic and symptomatic bacteriuria. Although a positive urine analysis for leukocytes and/or nitrites is considered an independent risk factor for postoperative urosepsis [50], well‐designed multicentre randomized controlled trials (RCTs) are required to evaluate outcomes of preoperative antibiotic administration in patients with negative midstream urine culture but positive urine analysis for leukocytes and/or nitrites. For patients with asymptomatic bacteruria, adequate antibiotics are required to control the UTI prior to RIRS. However, for patients with acute symptomatic bacteriuria, if fever or even septic shock is noted, nephrostomy tube or JJ stent are required for a period of drainage before lithotripsy.

Management of Antithrombotic Therapy

  • Cessation of antithrombotic therapy is not mandatory in patients undergoing RIRS (LE:3, GR:B).

Retrograde intrarenal surgery is categorized as a procedure with low bleeding risk, it is a safe and efficient modality for patients on anticoagulation or antiplatelet therapy [51], and discontinuation of antithrombotic therapy is not required prior to RIRS. However, some studies have suggested that antithrombotic therapy may increase the risk of procedure‐related bleeding [52], especially anticoagulation therapy (e.g., warfarin, direct oral anticoagulants, subcutaneous low‐molecular‐weight heparin), while antiplatelet therapy (e.g., aspirin, clopidogrel) does not [53, 54]. Therefore, there should be sufficient communication among surgeons, anaesthesiologists, physicians and patients prior to surgery, and patients on antithrombotic therapy should undergo RIRS by experienced surgeons.

Anaesthesia

  • Both general anaesthesia and regional anaesthesia are acceptable anaesthetic techniques for RIRS (LE:3, GR:A).

  • Regional anaesthesis may be an alternative to general anaesthesia, and patients may benefit from regional anaesthesia in terms of less postoperative pain and economic factors (LE:3, GR:B).

For RIRS, both general and regional anaesthesia and are well accepted anaesthetic modalities [55, 56, 57]. Patients may benefit from regional anaesthesia in terms of less postoperative pain and economic factors [55, 56], while general anaesthesia may provide better intra‐operative anaesthetic management and patient experience. General anaesthesia is preferred as it allows respiration to be controlled if position holding in holmium:YAG (Ho:YAG) laser lithotripsy for RIRS or puncture for ECIRS is needed [58]. Nevertheless, large‐sample, multicentre RCTs with strict standards should be performed to confirm these findings.

Intra‐operative Positioning

  • Standard lithotomy position is the most commonly used position for RIRS (LE:5, GR:A).

Besides the standard lithotomy position, other positions, such as the T‐tilt position, are also available for RIRS in special cases [59]. In cases of ECIRS, RIRS may be performed in the supine (supine or Galdakao‐modified supine Valdivia position) or prone split‐leg position [60, 61]. Both prone split‐leg position and supine positions are equally feasible in ECIRS, and are associated with similar SFRs [62].

Guidewire Placement

  • Placement of a safety guidewire as the first step in RIRS is recommended for the majority of ureteroscopic procedures (LE:3, GR:B).

Although some studies have demonstrated that placement of a safety guidewire may be omitted during RIRS, particularly when treating stones in the kidney [63, 64, 65], it is still generally recommended for the treatment of upper ureteric stones and/or if fragments will be manually extracted. The safety guidewire can facilitate rapid and easy stent placement in case of bleeding or ureteric injury. Retrograde urogram prior to guidewire placement would facilitate good understanding of the renal collecting system anatomy and location of the guidewire.

Ureteric Access Sheath Insertion

  • Placement of a UAS may facilitate RIRS, but there is no consistent evidence that it improves SFRs or reduces complication rates (LE:1, GR:A).

Ureteric access sheath placement may facilitate quick and multiple access to the renal collecting system and rapid extraction of stone fragments with basketing during RIRS. UAS placement could also provide a continuous outflow of irrigation and might reduce intrarenal pressure and infectious complications [66, 67]. However, studies have demonstrated that use of a UAS has no prominent impact on SFR or operation duration [68, 69], but does bring an increased risk of ureteric injury [70, 71]. Therefore, the placement of a UAS in RIRS may be considered a ‘double‐edged sword’ and should be carefully decided on in each case, taking into consideration its advantages and disadvantages, and surgeon's preference.

Although the insertion of a UAS without use of X‐ray is feasible in uncomplicated cases [72], this should be performed routinely under fluoroscopic control because of the risk of ureteric injury [73]. Ureteric balloon dilatation prior to UAS insertion should not be routine, however, it can be considered in cases of difficult access to the ureter [74]. Pre‐stenting is believed to passively dilate the ureter, to facilitate subsequent UAS insertion, and to reduce the risk of ureteric injury [22, 25]. However, pre‐stenting brings additional cost, radiation exposure and side effects from prolonged stenting [32].

Irrigation

  • Normal saline is the standard irrigation solution for RIRS (LE:3, GR:A).

  • Manual hand and automated irrigation methods provide similar operation times, SFRs and complication rates (LE:2, GR:B).

Although some studies demonstrated that irrigation with sterile water during endourological procedures can improve endoscopic vision [75, 76, 77], normal saline remains the preferred standard irrigation fluid as use of a non‐isotonic solution increases the risk of haemolysis, hyponatraemia, and heart failure if sufficient volume is absorbed [78, 79].

Manual hand pumps, automated irrigation pumps and gravity‐based irrigation are the options available to provide variable pressure irrigation during RIRS. Although the manual hand pump method has the advantages of easy control of irrigation flow and pressure, the pressure might still reach high levels if not well managed. Automated irrigation pumps provide a more consistent flow, however, a high continuous flow may cause high pressure, resulting in pyelovenous backflow [80].

Comparisons of operation time, SFR, complications and volume of irrigation fluid used in RIRS with a manual hand pump versus an automated irrigation pump are not well clarified [81, 82]. Further studies are needed to evaluate the irrigation flow, intrarenal pressure and effect on post‐procedure patient outcomes associated with using different irrigation methods.

Flexible Ureterorenoscopy

Single‐Use Flexible Ureterorenoscopes vs Reusable Flexible Ureterorenoscopes

  • Single‐use flexible ureterorenoscopes (su‐fURS) are comparable to reusable flexible ureterorenoscopes (re‐fURS) with regard to clinical effectiveness (LE:2, GR:A).

  • The durability and surgical outcomes of fibre‐optic and digital flexible ureterorenoscopes (fURS) are comparable, while fibre‐optic fURS usually have better end‐tip deflection and smaller calibre (LE:2, GR:B).

Single‐use flexible ureterorenoscopes overcome the main limitations of high initial acquisition and ongoing maintenance costs associated with re‐fURS [83, 84, 85, 86]. Furthermore, su‐fURS are well suited to anatomically complex and challenging cases, such as large stones (>2 cm), lower pole stone with steep infundibulopelvic angle, urinary diversion or unusual renal anatomy, due to the risk of inadvertent damage to the fURS [87, 88, 89, 90]. The use of su‐fURS may be more cost‐effective in low‐volume centres and in teaching hospitals with residents [89, 90]. These ureterorenoscopes are suitable for immunocompromised patients or patients with multidrug‐resistant bacterial infection to avoid the risk of cross‐infection [86, 87, 88, 89, 90]. However, regard should also be paid to the carbon emissions and environmental pollution associated with the use of su‐fURS versus re‐fURS; the recycling is required [91, 92].

There is no difference in surgical outcomes between the use of su‐fURS and re‐fURS [93, 94, 95, 96]. However, the manoeuvrability of su‐fURS may be inferior to that of re‐fURS, and fibre‐optic fURS usually have better end‐tip deflection and smaller calibre than digital fURS [94].

Working Channel (Single Channel vs Dual Channels)

  • Ureterorenoscopes with dual working channels may provide superior irrigation flow and visibility compared to single‐channel ureterorenoscopes (LE:3, GR:2).

The dual‐channel fURS provides similar deflection to the single‐channel fURS, but with more room in the working channel. Consequently, these ureterorenoscopes have better flow and visibility, particularly when employing instruments in the working channel. However, the large diameter of dual‐channel fURS necessitates a larger‐calibre UAS if an access sheath is desired, which potentially may result in strain‐induced ureteric injuries [97, 98, 99].

Miniaturization of the Flexible Ureterorenoscope

  • Miniaturization of the fURS will facilitate insertion of the ureterorenoscope and promote lower intrarenal pressure and improved visibility due to enhanced irrigation flow (LE:2, GR:1).

Miniaturizing ureterorenoscope size could facilitate insertion into a small‐calibre UAS, thereby reducing the risk of ureteric injury from an oversized UAS, especially in the case of a narrowed/tight ureter which cannot be accessed with a large‐calibre UAS [100]. Small‐calibre ureterorenoscopes provide increased outflow, lower intrarenal pressure and improved visibility when compared to large‐calibre ureterorenoscopes, with the premise of a UAS with the same calibre [101, 102].

Robotic Ureterorenoscope

  • Robot‐assisted RIRS provides similar outcomes to classic RIRS (LE:2, GR:2).

  • Robot‐assisted RIRS reduces occupational radiation exposure, but with high acquisition and maintenance costs, as well as space requirements (LE:2, GR:2).

Preliminary evidence indicates that robot‐assisted RIRS fails to offer any substantive advantage with regard to manoeuvrability and operation results when compared to conventional RIRS [103, 104]. Although robot‐assisted RIRS reduces occupational radiation exposure and manpower demand, the high acquisition and maintenance costs, as well as the space requirements within operating facilities, limit the widespread adoption of a robotic system for ureteroscopy [105, 106].

Laser Lithotripsy

  • Holmium:YAG laser is the conventional treatment modality for lithotripsy in RIRS, while the thulium fibre laser is a new, promising and viable alternative (LE:2, GR:B).

High‐power Ho:YAG laser devices used in RIRS may be associated with shorter operation time and higher SFR when compared to lower‐power Ho:YAG laser devices [107, 108, 109, 110].

Holmium:YAG laser with lower frequency, higher energy and shorter pulse duration settings fragment stones, while the Ho:YAG laser uses higher frequency, lower energy and longer pulse duration settings and has the ability to generate dusting [111, 112]. The thulium fibre laser is a new modality for lithotripsy in RIRS and has been shown to be both effective and safe. The versatility of the thulium fibre laser, including high frequencies and reduced retropulsion, may result in higher ablation efficiency when compared to the Ho:YAG laser [113, 114, 115, 116, 117]. However, the thermal effect with both Ho:YAG and thulium fibre lasers at higher settings should be taken into consideration, especially in case of narrow room with inadequate irrigation, and a prolonged procedure. Further study is required to confirm these findings.

Stone Retrieval

  • Both dusting and fragmentation with stone basketing are equivalent modalities in terms of stone clearance during RIRS (LE:2, GR:1)

  • Suction UAS may reduce stone retropulsion, improve stone clearance, improve visibility and reduce intrarenal pressure (LE:3, GR:1)

As there is little evidence to support one stone management strategy over another (dusting or fragmentation) [118, 119], individual decision making should be based on the stone characteristics and urologist preference. Dusting has been associated with shorter procedural duration, however, the number of stone‐related adverse events may be higher because stone fragments are left for spontaneous passage after RIRS [120]. The active removal of stone fragments with a basketing or suction technique may provide a higher initial SFR, however, multicentre RCTs are lacking to support these observations [121, 122, 123].

Exit Strategy

  • Removal of the UAS under direct vision as an exit strategy is recommended (LE:3, GR:A).

Removal of the UAS under direct vision as an exit strategy is imperative to detect inadvertent and unrecognized ureteric injury [124]. A JJ stent is usually placed to ensure adequate urine flow in the setting of ureteric injury and stone fragments [125]. The duration of postoperative stenting is contingent on the state of the ureter after the procedure, with longer stent duration for smaller‐calibre ureters, greater ureteric oedema and ureteric injury [126, 127]. However, JJ stenting may lead to LUTS in some patients [128].

The decision as to whether to leave a stent is therefore based on surgeon preference and patient factors. The JJ stent can be omitted in straightforward cases, or if the patient already has a stent in situ (following a previous primary treatment or stent insertion because of inability to access the upper tract adequately); this may have the benefit of avoiding the need for a postoperative stenting. A stent‐on‐string might alleviate the potential LUTS caused by conventional JJ stenting. Use of α‐blockers or anticholinergic agents are recommended to improve LUTS [129, 130, 131].

Postoperative Imaging and Stone‐Free Status Evaluation

  • Ultrasonography and KUB are adequate methods to identify evidence of residual stone fragments and dilatation suggestive of potential obstruction in follow‐up (LE:3, GR:A).

  • Stone‐free rate should be evaluated 3 months after RIRS, and NCCT is the most accurate method for this (LE:1, GR:A).

Ultrasonography, KUB and NCCT are commonly used imaging methods to assess SFR. KUB and ultrasonography are adequate methods to identify evidence of residual stone fragments and dilatation suggestive of potential obstruction in follow‐up [132], while NCCT is highly recommended in the determination of stone fragments less than 2 mm [133]. Low‐radiation dose NCCT is adequate for non‐obese patients (BMI <30 kg/m2), with a similar detection rate but lower expose dose when compared to NCCT.

Currently, stone‐free status is poorly defined in the literature, and the optimal timing of SFR evaluation remains undetermined. Further controlled studies with large samples are needed to define acceptable residual fragment size, timing and imaging modality to evaluate stone‐free status [134, 135].

Complications

The modified Clavien–Dindo classification system has generally been used to evaluate the presence and severity of complications following RIRS [136, 137, 138]. Most complications associated with RIRS are mild, with Clavien–Dindo grades I to III comprising 67.7%, 22.7% and 7.2% of complications, respectively, and severe complications (grade IV) representing only 2.4% [139].

Bleeding

  • Post‐RIRS bleeding is generally self‐limited, with severe bleeding complications being rare (LE:4, GR:A).

  • Severe bleeding is generally attributable to renal collecting system perforation from instrumentation, directly or indirectly, and sudden decompression after increased intrarenal pressure (LE:4, GR:A).

The risk of vascular complications after RIRS is very low. Potential vascular injury during RIRS may be the direct result of perforation of the ureter or collecting system by instrumentation (e.g., UAS insertion, use of Ho:YAG laser lithotripsy, guidewires or catheters) or it may be associated with chronic kidney disease, anticoagulation therapy or sudden decompression after high intrarenal pressure [136, 137, 140].

Ureteric perforation or avulsion have been reported most commonly during semi‐rigid ureteroscopy [141], although serious bleeding following these events is rare. However, perforation of the renal collecting system due to forcible insertion of a UAS may cause severe bleeding. The use of Ho:YAG laser lithotripsy can also cause bleeding through inadvertent thermal injury of the pelvic/calyceal mucosa, although this is generally self‐limited. Temporarily capping the UAS may promote clot formation and facilitate bleeding cessation.

Perirenal haematomas, pseudoaneurysm formation or arteriovenous fistula have been reported following RIRS [142, 143, 144, 145]. The risk increases in cases of UTI, intra‐operative high intrarenal pressure and prolonged operation time. In these events, angiography and superselective embolization is recommended as the first choice and, rarely, nephrectomy may be required [142, 143, 144, 145].

Infectious Complications

  • Intrarenal pressure and operating time should be limited in RIRS (LE:3, GR:A).

Postoperative infection is the most frequently noted complication resulting from RIRS. Postoperative fever (4.9%), sepsis (0.5%) and septic shock (0.3%) are the most commonly noted clinical symptoms [146].

Positive mid‐stream urine culture, infection stone, large stone burden, forced irrigation and prolonged operation duration are the main risk factors for post‐RIRS infection [147, 148, 149, 150, 151]. Emphasizing the preoperative adequate antibiotic treatment in patients with symptomatic bacteriuria, and avoidance of routine prolonged postoperative antibiotic use since a single‐dose prophylactic antibiotic is sufficient for patients without UTI. Common tips to prevent infectious complications include culture‐specific antibiotic therapy for documented preoperative UTI, broad‐spectrum antibiotic prophylaxis for culture‐negative patients, ensuring good outflow during the procedure with an appropriately placed UAS, good irrigation management, minimizing intra‐operative intrarenal pressure, avoiding prolonged operation time and leaving a Foley catheter in place [17, 146, 150]. Performance of RIRS using a suction device was reported to decrease intrarenal pressure and shorten operation time [122], and warrants further study as a measure to decrease the risk of postoperative infection.

Generally, postoperative fever due to UTI should resolve with culture‐specific antibiotics, while urosepsis and septic shock require early and rapid identification so that the appropriate action can be taken. Q‐SOFA scores (altered mental status [Glasgow Coma Scale score <15], hypotension [systolic blood pressure <100 mmHg], high respiratory rate [>22/min]) can provide a quick and easy way to assess potential urosepsis. White blood cell counts <3 × 109/L can also be an indicator of impending sepsis [151, 152]. Early appropriate antibiotic therapy, resuscitation support, transfusion or use of vasopressors, intubation or mechanical ventilation may be required to treat septic shock [153, 154].

Ureteric Injury

  • Pre‐stenting may result in passive dilatation of the ureter and therefore decrease the risk of UAS insertion‐related ureteric injury (LE:2, GR:A).

Ureteric injury following RIRS is thought to be under‐reported because the ureter is not routinely inspected after removal of UAS [140, 155]. The ureter should therefore be directly inspected routinely on removal of the ureterorenoscope and UAS following RIRS, and ureter wall injuries should be classified according to the Endoscopic Classification System [125, 156]. Indeed, ureteric wall injuries are much more frequently noted with this approach, with an incidence rate of 30.4–46.5% [125, 156].

Mild mucosal abrasion and superficial lesions do not require special measures other than 10–14 days of ureteric stenting. However, stent duration should be extended to up to 6 weeks for ureteric perforation [141, 157]. Ureteric reconstruction is required in case of a complete ureteric avulsion [141, 157].

Conclusion

The series of recommendations regarding RIRS along with the related commentary and supporting documentation provided here should help provide safe and effective performance of RIRS.

Disclosures of Interest

None declared.

Abbreviations

ECIRS

endoscopic combined intrarenal surgery

Ho:YAG

holmium:YAG

IAU

International Alliance of Urolithiasis

KUB

plain abdominal film of kidney, ureter and bladder

NCCT

non‐contrast CT

PCNL

percutaneous nephrolithotomy

RCT

randomized controlled trial

RIRS

retrograde intrarenal surgery

ru‐fURS

reusable flexible ureterorenoscope

SFR

stone‐free rate

su‐fURS

single‐use flexible ureterorenoscope

UAS

ureteric access sheath

G.Z., O.T. and W.Z. contributed equally to this work, as co‐first authors.

Contributor Information

Guohua Zeng, Email: gzgyzgh@vip.sina.com.

Kemal Sarica, Email: saricakemal@gmail.com.

References

  • 1. Assimos D, Krambeck A, Miller NL et al. Surgical management of stones: American urological association/endourological society guideline. J Urol 2016; 196: 1153–69 [DOI] [PubMed] [Google Scholar]
  • 2. EAU Guidelines . Edn. presented at the EAU Annual Congress Amsterdam, 2022. ISBN 978‐94‐92671‐16‐5. Available at: https://uroweb.org/guidelines/urolithiasis. Accessed June 2022
  • 3. Zeng G, Zhao Z, Mazzon G, Pearle M et al. European Association of Urology section of urolithiasis and international alliance of urolithiasis joint consensus on retrograde intrarenal surgery for the management of renal stones. Eur Urol Focus 2021; S2405‐4569(21)00290‐X. 10.1016/j.euf.2021.10.011 [DOI] [PubMed] [Google Scholar]
  • 4. Zeng G, Zhong W, Mazzon G et al. International Alliance of Urolithiasis (IAU) guideline on percutaneous nephrolithotomy. Minerva Urol Nephrol 2022. 10.23736/S2724-6051.22.04752-8 [DOI] [PubMed] [Google Scholar]
  • 5. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. OCEBM Levels of Evidence Working Group . OCEBM levels of evidence. Available at: http://www.cebm.net. Accessed June 2022
  • 7. Hyams ES, Monga M, Pearle MS et al. A prospective, multi‐institutional study of flexible ureteroscopy for proximal ureteral stones smaller than 2 cm. J Urol 2015; 193: 165–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Sener NC, Imamoglu MA, Bas O et al. Prospective randomized trial comparing shock wave lithotripsy and flexible ureterorenoscopy for lower pole stones smaller than 1 cm. Urolithiasis 2014; 42: 127–31 [DOI] [PubMed] [Google Scholar]
  • 9. El‐Nahas AR, Ibrahim HM, Youssef RF et al. Flexible ureterorenoscopy versus extracorporeal shock wave lithotripsy for treatment of lower pole stones of 10‐20 mm. BJU Int 2012; 110: 898–902 [DOI] [PubMed] [Google Scholar]
  • 10. Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A. Retrograde intrarenal surgery versus percutaneous nephrolithotomy in the management of lower‐pole renal stones with a diameter of 15 to 20 mm. J Endourol 2011; 25: 1131–5 [DOI] [PubMed] [Google Scholar]
  • 11. Zhang W, Zhou T, Wu T et al. Retrograde intrarenal surgery versus percutaneous nephrolithotomy versus extracorporeal shockwave lithotripsy for treatment of lower pole renal stones: a meta‐analysis and systematic review. J Endourol 2015; 29: 745–59 [DOI] [PubMed] [Google Scholar]
  • 12. Hamamoto S, Yasui T, Okada A et al. Endoscopic combined intrarenal surgery for large calculi: simultaneous use of flexible ureteroscopy and mini‐percutaneous nephrolithotomy overcomes the disadvantageous of percutaneous nephrolithotomy monotherapy. J Endourol 2014; 28: 28–33 [DOI] [PubMed] [Google Scholar]
  • 13. Breda A, Ogunyemi O, Leppert JT, Lam JS, Schulam PG. Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater—is this the new frontier? J Urol 2008; 179: 981–4 [DOI] [PubMed] [Google Scholar]
  • 14. Cohen J, Cohen S, Grasso M. Ureteropyeloscopic treatment of large, complex intrarenal and proximal ureteral calculi. BJU Int 2013; 111: E127–31 [DOI] [PubMed] [Google Scholar]
  • 15. Geraghty R, Abourmarzouk O, Rai B, Biyani CS, Rukin NJ, Somani BK. Evidence for ureterorenoscopy and laser fragmentation (URSL) for large renal stones in the modern era. Curr Urol Rep 2015; 16: 54 [DOI] [PubMed] [Google Scholar]
  • 16. Zeng G, Zhu W, Li J et al. The comparison of minimally invasive percutaneous nephrolithotomy and retrograde intrarenal surgery for stones larger than 2 cm in patients with a solitary kidney: a matched‐pair analysis. World J Urol 2015; 33: 1159–64 [DOI] [PubMed] [Google Scholar]
  • 17. Zhong W, Leto G, Wang L, Zeng G. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors. J Endourol 2015; 29: 25–8 [DOI] [PubMed] [Google Scholar]
  • 18. Baboudjian M, Gondran‐Tellier B, Abdallah R et al. Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications. World J Urol 2020; 38: 1253–9 [DOI] [PubMed] [Google Scholar]
  • 19. Martov A, Gravas S, Etemadian M et al. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case‐control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol 2015; 29: 171–80 [DOI] [PubMed] [Google Scholar]
  • 20. Zeng G, Zhao Z, Yang F, Zhong W, Wu W, Chen W. Retrograde intrarenal surgery with combined spinal‐epidural vs general anesthesia: a prospective randomized controlled trial. J Endourol 2015; 29: 401–5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Guzel O, Tuncel A, Balci M et al. Retrograde intrarenal surgery is equally efficient and safe in patients with different American Society of Anesthesia physical status. Ren Fail 2016; 38: 503–7 [DOI] [PubMed] [Google Scholar]
  • 22. Hoare DT, Wollin TA, De S, Hobart MG. Success rate of repeat flexible ureteroscopy following previous failed access: an analysis of stent duration. Can Urol Assoc J 2021; 15: 255–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Bai P, Wang T, Huang H‐C et al. Effect of preoperative double‐J ureteral stenting before flexible ureterorenoscopy on stone‐free rates and complications. Curr Med Sci 2021; 41: 140–4 [DOI] [PubMed] [Google Scholar]
  • 24. Dessyn J‐F, Balssa L, Chabannes E et al. Flexible ureterorenoscopy for renal and proximal ureteral stone in patients with previous ureteral stenting: impact on stone‐free rate and morbidity. J Endourol 2016; 30: 1084–8 [DOI] [PubMed] [Google Scholar]
  • 25. Fahmy O, Shsm H, Lee C, Khairul‐Asri MG. Impact of preoperative stenting on the outcome of flexible ureterorenoscopy for upper urinary tract urolithiasis: a systematic review and meta‐analysis. Urol Int 2021; 25: 1–9 [DOI] [PubMed] [Google Scholar]
  • 26. Netsch C, Knipper S, Bach T, Herrmann TRW, Gross AJ. Impact of preoperative ureteral stenting on stone‐free rates of ureteroscopy for nephroureterolithiasis: a matched‐paired analysis of 286 patients. Urology 2012; 80: 1214–9 [DOI] [PubMed] [Google Scholar]
  • 27. Lumma PP, Schneider P, Strauss A et al. Impact of ureteral stenting prior to ureterorenoscopy on stone‐free rates and complications. World J Urol 2013; 31: 855–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. L'esperance JO, Ekeruo WO, Scales CD Jr et al. Effect of ureteral access sheath on stone‐free rates in patients undergoing ureteroscopic management of renal calculi. Urology 2005; 66: 252–5 [DOI] [PubMed] [Google Scholar]
  • 29. Kawahara T, Ito H, Terao H et al. Preoperative stenting for ureteroscopic lithotripsy for a large renal stone. Int J Urol Off J Jpn Urol Assoc 2012; 19: 881–5 [DOI] [PubMed] [Google Scholar]
  • 30. Yuk HD, Park J, Cho SY, Sung LH, Jeong CW. The effect of preoperative ureteral stenting in retrograde intrarenal surgery: a multicenter, propensity score‐matched study. BMC Urol 2020; 20: 147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Lee MH, Lee IJ, Kim TJ et al. The effect of short‐term preoperative ureteral stenting on the outcomes of retrograde intrarenal surgery for renal stones. World J Urol 2019; 37: 1435–40 [DOI] [PubMed] [Google Scholar]
  • 32. Falagario UG, Calò B, Auciello M, Carrieri G, Cormio L. Advanced ureteroscopic techniques for the management of kidney stones. Curr Opin Urol 2021; 31: 58–65 [DOI] [PubMed] [Google Scholar]
  • 33. Xie Y, Tao J, Liu H et al. The use of low‐dose CT with adaptive statisstical iterative reconstruction for the diagnosis of urinary calculi. Radiat Prot Dosimetry 2020; 190: 200–7 [DOI] [PubMed] [Google Scholar]
  • 34. Joyce S, O'Connor OJ, Maher MM, McEntee MF. Strategies for dose reduction with specific clinical indications during computed tomography. Radiography(Lond) 2020; 26: S62–8 [DOI] [PubMed] [Google Scholar]
  • 35. Roberts MJ, Williams J, Khadra S et al. A prospective, matched comparison of ultra‐low and standard‐dose computed tomography for assessment of renal colic. BJU Int 2020; 126: 27–32 [DOI] [PubMed] [Google Scholar]
  • 36. Karsiyakali N, Karabay E, Erkan E, Kadihasanoglu M. Evaluation of nephrolithometric scoring systems to predict outcomes of retrograde intrarenal surgery. Urol J 2020; 17: 352–7 [DOI] [PubMed] [Google Scholar]
  • 37. Danilovic A, Rocha BA, Torricelli FCM et al. Size is not everything that matters: preoperative CT predictors of stone free after RIRS. Urology 2019; 132: 63–8 [DOI] [PubMed] [Google Scholar]
  • 38. Koc E, Kamaci D, Gok B, Bedir F, Metin BC, Atmaca AF. Does the renal parenchymal thickness affect the efficacy of the retrograde intrarenal surgery? A prospective cohort study. Urolithiasis 2021; 49: 57–64 [DOI] [PubMed] [Google Scholar]
  • 39. Kim DS, Moon SK, Lee SH. Histogram of kidney stones on non‐contrast computed tomography to predict successful stone dusting during retrograde intrarenal surgery. World J Urol 2021; 39: 3563–9 [DOI] [PubMed] [Google Scholar]
  • 40. Tastemur S, Senel S, Kizilkan Y, Ozden C. Evaluation of the anatomical factors affecting the success of retrograde intrarenal surgery for isolated lower pole kidney stones. Urolithiasis 2021; 50: 65–70 [DOI] [PubMed] [Google Scholar]
  • 41. Hu H, Hu X‐Y, Fang X‐M, Chen H‐W, Yao X‐J. Unenhanced helical CT following excretory urography in the diagnosis of upper urinary tract disease: a little more cost, a lot more value. Urol Res 2010; 38: 127–33 [DOI] [PubMed] [Google Scholar]
  • 42. Xu Y, Lyu J‐L. The value of three‐dimensional helical computed tomography for the retrograde flexible ureteronephroscopy in the treatment of lower pole calyx stones. Chronic Dis Transl Med 2016; 2: 42–7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Kaler KS, Safiullah S, Lama DJ et al. Medical impulsive therapy (MIT): the impact of 1 week of preoperative tamsulosin on deployment of 16‐French ureteral access sheaths without preoperative ureteral stent placement. World J Urol 2018; 36: 2065–71 [DOI] [PubMed] [Google Scholar]
  • 44. Kim JK, Choi CI, Lee SH et al. Silodosin for prevention of ureteral injuries resulting from insertion of a ureteral access sheath: a randomized controlled trial. Eur Urol Focus 2022; 8: 572–79 [DOI] [PubMed] [Google Scholar]
  • 45. Tapiero S, Kaler KS, Jiang P et al. Determining the safety threshold for the passage of a ureteral access sheath in clinical practice using a purpose‐built force sensor. J Urol 2021; 206: 364–72 [DOI] [PubMed] [Google Scholar]
  • 46. Koo KC, Yoon J‐H, Park N‐C et al. The impact of preoperative α‐adrenergic antagonists on ureteral access sheath insertion force and the upper limit of force required to avoid ureteral mucosal injury: a randomized controlled study. J Urol 2018; 199: 1622–30 [DOI] [PubMed] [Google Scholar]
  • 47. Zhao Z, Fan J, Sun H et al. Recommended antibiotic prophylaxis regimen in retrograde intrarenal surgery: evidence from a randomised controlled trial. BJU Int 2019; 124: 496–503 [DOI] [PubMed] [Google Scholar]
  • 48. Deng T, Liu B, Duan X et al. Antibiotic prophylaxis in ureteroscopic lithotripsy: a systematic review and meta‐analysis of comparative studies. BJU Int 2018; 122: 29–39 [DOI] [PubMed] [Google Scholar]
  • 49. Wolf JS Jr, Bennett CJ, Dmochowski RR et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008; 179: 1379–90 [DOI] [PubMed] [Google Scholar]
  • 50. Jian ZY, Ma YC, Liu R, Li H, Wang K. Preoperative positive urine nitrite and albumin‐globulin ratio are independent risk factors for predicting postoperative fever after retrograde intrarenal surgery based on a retrospective cohort. BMC Urol 2020; 20: 50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Culkin DJ, Exaire EJ, Green D et al. Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper. J Urol 2014; 192: 1026–34 [DOI] [PubMed] [Google Scholar]
  • 52. Sharaf A, Amer T, Somani BK, Aboumarzouk OM. Ureteroscopy in patients with bleeding diatheses, anticoagulated, and on anti‐platelet agents: a systematic review and meta‐analysis of the literature. J Endourol 2017; 31: 1217–25 [DOI] [PubMed] [Google Scholar]
  • 53. Westerman ME, Scales JA, Sharma V, Gearman DJ, Ingimarsson JP, Krambeck AE. The effect of anticoagulation on bleeding‐related complications following ureteroscopy. Urology 2017; 100: 45–52 [DOI] [PubMed] [Google Scholar]
  • 54. Westerman ME, Sharma V, Scales J, Gearman DJ, Ingimarsson JP, Krambeck AE. The effect of antiplatelet agents on bleeding‐related complications after ureteroscopy. J Endourol 2016; 30: 1073–8 [DOI] [PubMed] [Google Scholar]
  • 55. Luo Z, Jiao B, Zhao H, Huang T, Zhang G. Comparison of retrograde intrarenal surgery under regional versus general anaesthesia: a systematic review and meta‐analysis. Int J Surg 2020; 82: 36–42 [DOI] [PubMed] [Google Scholar]
  • 56. Çakici MÇ, Özok HU, Erol D et al. Comparison of general anesthesia and combined spinal‐epidural anesthesia for retrograde intrarenal surgery. Minerva Urol Nefrol 2019; 71: 636–43 [DOI] [PubMed] [Google Scholar]
  • 57. Olivero A, Ball L, Fontaneto C et al. Spinal versus general anesthesia during retrograde intra‐renal surgery: a propensity score matching analysis. Curr Urol 2021; 15: 106–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. El Sayed H, Moawad AS, Hefnawy E. Spinal vs. general anesthesia for percutaneous nephrolithotomy: a prospective randomized trial. Egypt J Anaesth 2015; 31: 71–5 [Google Scholar]
  • 59. Liaw CW, Khusid JA, Gallante B, Bamberger JN, Atallah WM, Gupta M. The T‐tilt position: a novel modified patient position to improve stone‐free rates in retrograde intrarenal surgery. J Urol 2021; 206: 1232–9 [DOI] [PubMed] [Google Scholar]
  • 60. Cracco CM, Scoffone CM. ECIRS (endoscopic combined intrarenal surgery) in the Galdakao‐modified supine Valdivia position: a new life for percutaneous surgery? World J Urol 2011; 29: 821–7 [DOI] [PubMed] [Google Scholar]
  • 61. Scoffone CM, Cracco CM. Invited review: the tale of ECIRS (endoscopic combined IntraRenal surgery) in the Galdakao‐modified supine Valdivia position. Urolithiasis 2018; 46: 115–23 [DOI] [PubMed] [Google Scholar]
  • 62. Kawase K, Okada T, Chaya R et al. Comparison of the safety and efficacy between the prone split‐leg and Galdakao‐modified supine Valdivia positions during endoscopic combined intrarenal surgery: a multi‐institutional analysis. Int J Urol 2021; 28: 1129–35 [DOI] [PubMed] [Google Scholar]
  • 63. Eandi JA, Hu B, Low RK. Evaluation of the impact and need for use of a safety guidewire during ureteroscopy. J Endourol 2008; 22: 1653–8 [DOI] [PubMed] [Google Scholar]
  • 64. Dickstein RJ, Kreshover JE, Babayan RK, Wang DS. Is a safety wire necessary during routine flexible ureteroscopy? J Endourol 2010; 24: 1589–92 [DOI] [PubMed] [Google Scholar]
  • 65. Ulvik Ø, Rennesund K, Gjengstø P, Wentzel‐Larsen T, Ulvik NM. Ureteroscopy with and without safety guide wire: should the safety wire still be mandatory? J Endourol 2013; 27: 1197–202 [DOI] [PubMed] [Google Scholar]
  • 66. Stern JM, Yiee J, Park S. Safety and efficacy of ureteral access sheaths. J Endourol 2007; 21: 119–23 [DOI] [PubMed] [Google Scholar]
  • 67. Özkaya F, Sertkaya Z, Karabulut İ, Aksoy Y. The effect of using ureteral access sheath for treatment of impacted ureteral stones at mid‐upper part with flexible ureterorenoscopy: a randomized prospective study. Minerva Urol Nefrol 2019; 71: 413–20 [DOI] [PubMed] [Google Scholar]
  • 68. Yitgin Y, Yitgin E, Verep S, Gasimov K, Tefik T, Karakose A. Is access sheath essential for safety and effective retrograde intrarenal stone surgery? J Coll Physicians Surg Pak 2021; 31: 1202–6 [DOI] [PubMed] [Google Scholar]
  • 69. Huang J, Zhao Z, AlSmadi JK et al. Use of the ureteral access sheath during ureteroscopy: a systematic review and meta‐analysis. PLoS One 2018; 13: e0193600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Damar E, Senocak C, Ozbek R et al. Does ureteral access sheath affect the outcomes of retrograde intrarenal surgery: a prospective study. Minim Invasive Ther Allied Technol 2022; 31: 777–81 [DOI] [PubMed] [Google Scholar]
  • 71. Meier K, Hiller S, Dauw C et al. Understanding ureteral access sheath use within a statewide collaborative and its effect on surgical and clinical outcomes. J Endourol 2021; 35: 1340–7 [DOI] [PubMed] [Google Scholar]
  • 72. Aykac A, Baran O, Sari S. Ureteral access sheath application without fluoroscopy in retrograde intrarenal surgery. J Coll Physicians Surg Pak 2020; 30: 503–7 [DOI] [PubMed] [Google Scholar]
  • 73. Kaler KS, Lama DJ, Safiullah S et al. Ureteral access sheath deployment: how much force is too much? Initial studies with a novel ureteral access sheath force sensor in the porcine ureter. J Endourol 2019; 33: 712–8 [DOI] [PubMed] [Google Scholar]
  • 74. Kuntz NJ, Neisius A, Tsivian M et al. Balloon dilation of the ureter: a contemporary review of outcomes and complications. J Urol 2015; 194: 413–7 [DOI] [PubMed] [Google Scholar]
  • 75. Aghamir SM, Alizadeh F, Meysamie A, Assefi Rad S, Edrisi L. Sterile water versus isotonic saline solution as irrigation fluid in percutaneous nephrolithotomy. Urol J 2009; 6: 249–53 [PubMed] [Google Scholar]
  • 76. Hosseini MM, Hassanpour A, Manaheji F, Yousefi A, Damshenas MH, Haghpanah S. Percutaneous nephrolithotomy: is distilled water as safe as saline for irrigation? Urol J 2014; 11: 1551–6 [PubMed] [Google Scholar]
  • 77. Pirani F, Makhani SS, Kim FY et al. Prospective randomized trial comparing the safety and clarity of water versus saline irrigant in ureteroscopy. Eur Urol Focus 2021; 7: 850–6 [DOI] [PubMed] [Google Scholar]
  • 78. Chen SS, Lin AT, Chen KK, Chang LS. Hemolysis in transurethral resection of the prostate using distilled water as the irrigant. J Chin Med Assoc 2006; 69: 270–5 [DOI] [PubMed] [Google Scholar]
  • 79. Guzelburc V, Balasar M, Colakogullari M et al. Comparison of absorbed irrigation fluid volumes during retrograde intrarenal surgery and percutaneous nephrolithotomy for the treatment of kidney stones larger than 2 cm. Springerplus 2016; 5: 1707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Lama DJ, Owyong M, Parkhomenko E, Patel RM, Landman J, Clayman RV. Fluid dynamic analysis of hand‐pump infuser and UROMAT endoscopic automatic system for irrigation through a flexible ureteroscope. J Endourol 2018; 32: 431–6 [DOI] [PubMed] [Google Scholar]
  • 81. Doersch KM, Hart KD, Elmekresh A, Milburn PA, Machen GL, El Tayeb MM. Comparison of utilization of pressurized automated versus manual hand irrigation during ureteroscopy in the absence of ureteral access sheath. Proc (Bayl Univ Med Cent) 2018; 31: 432–5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Jefferson FA, Sung JM, Limfueco L et al. Prospective randomized comparison of standard hand pump infuser irrigation vs an automated irrigation pump during percutaneous nephrolithotomy and ureteroscopy: assessment of operating room efficiency and surgeon satisfaction. J Endourol 2020; 34: 156–62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Meng C, Peng L, Li J, Li Y, Li J, Wu J. Comparison between single‐use flexible ureteroscope and reusable flexible ureteroscope for upper urinary calculi: a systematic review and meta‐analysis. Front Surg 2021; 8: 691170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Li Y, Chen J, Zhu Z et al. Comparison of single‐use and reusable flexible ureteroscope for renal stone management: a pooled analysis of 772 patients. Transl Androl Urol 2021; 10: 483–93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Ma YC, Jian ZY, Jin X, Li H, Wang KJ. Stone removing efficiency and safety comparison between single use ureteroscope and reusable ureteroscope: a systematic review and meta‐analysis. Transl Androl Urol 2021; 10: 1627–36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Mager R, Kurosch M, Höfner T, Frees S, Haferkamp A, Neisius A. Clinical outcomes and costs of reusable and single‐use flexible ureterorenoscopes: a prospective cohort study. Urolithiasis 2018; 46: 587–93 [DOI] [PubMed] [Google Scholar]
  • 87. Ventimiglia E, Somani BK, Traxer O. Flexible ureteroscopy: reuse? Or is single use the new direction? Curr Opin Urol 2020; 30: 113–9 [DOI] [PubMed] [Google Scholar]
  • 88. Talso M, Goumas IK, Kamphuis GM et al. Reusable flexible ureterorenoscopes are more cost‐effective than single‐use scopes: results of a systematic review from PETRA Uro‐group. Transl Androl Urol 2019; 8: S418–25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Ozimek T, Schneider MH, Hupe MC et al. Retrospective cost analysis of a single‐center reusable flexible ureterorenoscopy program: a comparative cost simulation of disposable fURS as an alternative. J Endourol 2017; 31: 1226–30 [DOI] [PubMed] [Google Scholar]
  • 90. Somani BK, Talso M, Bres‐Niewada E. Current role of single‐use flexible ureteroscopes in the management of upper tract stone disease. Cent European J Urol 2019; 72: 183–4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Davis NF, McGrath S, Quinlan M, Jack G, Lawrentschuk N, Bolton DM. Carbon footprint in flexible ureteroscopy: a comparative study on the environmental impact of reusable and single‐use ureteroscopes. J Endourol 2018; 32: 214–7 [DOI] [PubMed] [Google Scholar]
  • 92. Bahaee J, Plott J, Ghani KR. Single‐use flexible ureteroscopes: how to choose and what is around the corner? Curr Opin Urol 2021; 31: 87–94 [DOI] [PubMed] [Google Scholar]
  • 93. Temiz MZ, Colakerol A, Ertas K, Tuken M, Yuruk E. Fiberoptic versus digital: a comparison of durability and cost effectiveness of the two flexible ureteroscopes. Urol Int 2019; 102: 181–6 [DOI] [PubMed] [Google Scholar]
  • 94. Dragos LB, Somani BK, Sener ET et al. Which flexible ureteroscopes (digital vs. fiber‐optic) can easily reach the difficult lower pole calices and have better end‐tip deflection: in vitro study on K‐Box. A PETRA evaluation. J Endourol 2017; 31: 630–7 [DOI] [PubMed] [Google Scholar]
  • 95. Proietti S, Dragos L, Molina W, Doizi S, Giusti G, Traxer O. Comparison of new single‐use digital flexible ureteroscope versus nondisposable fiber optic and digital ureteroscope in a cadaveric model. J Endourol 2016; 30: 655–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Multescu R, Geavlete B, Georgescu D, Geavlete P. Conventional fiberoptic flexible ureteroscope versus fourth generation digital flexible ureteroscope: a critical comparison. J Endourol 2010; 24: 17–21 [DOI] [PubMed] [Google Scholar]
  • 97. Lusch A, Okhunov Z, del Junco M et al. Comparison of optics and performance of single channel and a novel dual‐channel fiberoptic ureteroscope. Urology 2015; 85: 268–72 [DOI] [PubMed] [Google Scholar]
  • 98. Haberman K, Ortiz‐Alvarado O, Chotikawanich E, Monga M. A dual‐channel flexible ureteroscope: evaluation of deflection, flow, illumination, and optics. J Endourol 2011; 25: 1411–4 [DOI] [PubMed] [Google Scholar]
  • 99. Ng YH, Somani BK, Dennison A, Kata SG, Nabi G, Brown S. Irrigant flow and intrarenal pressure during flexible ureteroscopy: the effect of different access sheaths, working channel instruments, and hydrostatic pressure. J Endourol 2010; 24: 1915–20 [DOI] [PubMed] [Google Scholar]
  • 100. Zelenko N, Coll D, Rosenfeld AT, Smith RC. Normal ureter size on unenhanced helical CT. AJR Am J Roentgenol 2004; 182: 1039–41 [DOI] [PubMed] [Google Scholar]
  • 101. Tokas T, Herrmann TRW, Skolarikos A, Nagele U, Training and Research in Urological Surgery and Technology (T.R.U.S.T.)‐Group . Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol 2019; 37: 125–31 [DOI] [PubMed] [Google Scholar]
  • 102. Sener TE, Cloutier J, Villa L et al. Can we provide low intrarenal pressures with good irrigation flow by decreasing the size of ureteral access sheaths? J Endourol 2016; 30: 49–55 [DOI] [PubMed] [Google Scholar]
  • 103. Saglam R, Muslumanoglu AY, Tokatlı Z et al. A new robot for flexible ureteroscopy: development and early clinical results (IDEAL stage 1‐2b). Eur Urol 2014; 66: 1092–100 [DOI] [PubMed] [Google Scholar]
  • 104. Geavlete P, Saglam R, Georgescu D et al. Robotic flexible ureteroscopy versus classic flexible ureteroscopy in renal stones: the initial Romanian experience. Chirurgia (Bucur) 2016; 111: 326–9 [PubMed] [Google Scholar]
  • 105. Suntharasivam T, Mukherjee A, Luk A, Aboumarzouk O, Somani B, Rai BP. The role of robotic surgery in the management of renal tract calculi. Transl Androl Urol 2019; 8: S457–60 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Rassweiler J, Fiedler M, Charalampogiannis N, Kabakci AS, Saglam R, Klein JT. Robot‐assisted flexible ureteroscopy: an update. Urolithiasis 2018; 46: 69–77 [DOI] [PubMed] [Google Scholar]
  • 107. Sari S, Çakici MÇ, Kartal IG et al. Comparison of the efficiency, safety and pain scores of holmium laser devices working with 20 watt and 30 watt using in retrograde intrarenal surgery: one center prospective study. Arch Ital Urol Androl 2020; 92. 10.4081/aiua.2020.2.149 [DOI] [PubMed] [Google Scholar]
  • 108. Karakoyunlu N, Çakıcı MÇ, Sarı S et al. Efficacy of various laser devices on lithotripsy in retrograde intrarenal surgery used to treat 1‐2 cm kidney stones: a prospective randomized study. Int J Clin Pract 2021; 75: e14216 [DOI] [PubMed] [Google Scholar]
  • 109. Pietropaolo A, Hughes T, Mani M, Somani B. Outcomes of ureteroscopy and laser stone fragmentation (URSL) for kidney stone disease (KSD): comparative cohort study using MOSES technology 60 W laser system versus regular holmium 20 W laser. J Clin Med 2021; 10: 2742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Mekayten M, Lorber A, Katafigiotis I et al. Will stone density stop being a key factor in endourology? The impact of stone density on laser time using Lumenis laser p120w and standard 20 W laser: a comparative study. J Endourol 2019; 33: 585–9 [DOI] [PubMed] [Google Scholar]
  • 111. Aldoukhi AH, Roberts WW, Hall TL, Ghani KR. Holmium laser lithotripsy in the new stone age: dust or bust? Front Surg 2017; 4: 57 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Chen S, Fu N, Cui W, Zhao Z, Luo X. Comparison of stone dusting efficiency when using different energy settings of holmium: YAG laser for flexible ureteroscopic lithotripsy in the treatment of upper urinary tract calculi. Urol J 2019; 17: 224–7 [DOI] [PubMed] [Google Scholar]
  • 113. Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with holmium:YAG laser. World J Urol 2020; 38: 1883–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Traxer O, Corrales M. Managing urolithiasis with thulium fiber laser: updated real‐life results‐a systematic review. J Clin Med 2021; 10: 3390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Martov AG, Ergakov DV, Guseynov M, Andronov AS, Plekhanova OA. Clinical comparison of super pulse thulium fiber laser and high‐power holmium laser for ureteral stone management. J Endourol 2021; 35: 795–800 [DOI] [PubMed] [Google Scholar]
  • 116. Jones P, Beisland C, Ulvik Ø. Current status of thulium fibre laser lithotripsy: an up‐to‐date review. BJU Int 2021; 128: 531–8 [DOI] [PubMed] [Google Scholar]
  • 117. Enikeev D, Taratkin M, Klimov R et al. Superpulsed thulium fiber laser for stone dusting: in search of a perfect ablation regimen—a prospective single‐center study. J Endourol 2020; 34: 1175–9 [DOI] [PubMed] [Google Scholar]
  • 118. Matlaga BR, Chew B, Eisner B et al. Ureteroscopic laser lithotripsy: a review of dusting vs fragmentation with extraction. J Endourol 2018; 32: 1–6 [DOI] [PubMed] [Google Scholar]
  • 119. Weiss B, Shah O. Evaluation of dusting versus basketing – can new technologies improve stone‐free rates? Nat Rev Urol 2016; 13: 726–33 [DOI] [PubMed] [Google Scholar]
  • 120. Wenzel M, Bultitude M, Salem J. Dusting, fragmenting, popcorning or dustmenting? Curr Opin Urol 2019; 29: 108–12 [DOI] [PubMed] [Google Scholar]
  • 121. Huang J, Xie D, Xiong R et al. The application of suctioning flexible ureteroscopy with intelligent pressure control in treating upper urinary tract calculi on patients with a solitary kidney. Urology 2018; 111: 44–7 [DOI] [PubMed] [Google Scholar]
  • 122. Deng X, Song L, Xie D et al. A novel flexible ureteroscopy with intelligent control of intrarenal pressure: an initial experience of 93 cases. J Endourol 2016; 30: 1067–72 [DOI] [PubMed] [Google Scholar]
  • 123. Zeng G, Wang D, Zhang T, Wan SP. Modified access sheath for continuous flow Ureteroscopic lithotripsy: a preliminary report of a novel concept and technique. J Endourol 2016; 30: 992–6 [DOI] [PubMed] [Google Scholar]
  • 124. Tepeler A, Resorlu B, Sahin T et al. Categorization of intraoperative ureteroscopy complications using modified Satava classification system. World J Urol 2014; 32: 131–6 [DOI] [PubMed] [Google Scholar]
  • 125. Traxer O, Thomas A. Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery. J Urol 2013; 189: 580–4 [DOI] [PubMed] [Google Scholar]
  • 126. Shigemura K, Yasufuku T, Yamanaka K, Yamahsita M, Arakawa S, Fujisawa M. How long should double J stent be kept in after ureteroscopic lithotripsy? Urol Res 2012; 40: 373–6 [DOI] [PubMed] [Google Scholar]
  • 127. Ozyuvali E, Resorlu B, Oguz U et al. Is routine ureteral stenting really necessary after retrograde intrarenal surgery? Arch Ital Urol Androl 2015; 87: 72–5 [DOI] [PubMed] [Google Scholar]
  • 128. Fischer KM, Louie M, Mucksavage P. Ureteral stent discomfort and its management. Curr Urol Rep 2018; 19: 64 [DOI] [PubMed] [Google Scholar]
  • 129. Dellis A, Joshi HB, Timoney AG, Keeley FX. Relief of stent related symptoms: review of engineering and pharmacological solutions. J Urol 2010; 184: 1267–72 [DOI] [PubMed] [Google Scholar]
  • 130. Oh JJ, Lee S, Cho SY et al. Effects of naftopidil on double‐J stent‐related discomfort: a multicenter, randomized, double‐blinded, placebo‐controlled study. Sci Rep 2017; 7: 4154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Meta‐analysis showing the beneficial effect of α‐blockers on ureteric stent discomfort. BJU Int 2011; 108: 1894–902 [DOI] [PubMed] [Google Scholar]
  • 132. Fulgham PF, Assimos DG, Pearle MS, Preminger GM. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol 2013; 189: 1203–13 [DOI] [PubMed] [Google Scholar]
  • 133. Ulvik Ø, Harneshaug JR, Gjengstø P. What do we mean by "stone free," and how accurate are urologists in predicting stone‐free status following ureteroscopy? J Endourol 2021; 35: 961–6 [DOI] [PubMed] [Google Scholar]
  • 134. Omar M, Chaparala H, Monga M, Sivalingam S. Contemporary imaging practice patterns following ureteroscopy for stone disease. J Endourol 2015; 29: 1122–5 [DOI] [PubMed] [Google Scholar]
  • 135. Ito K, Takahashi T, Somiya S, Kanno T, Higashi Y, Yamada H. Predictors of repeat surgery and stone‐related events after flexible ureteroscopy for renal stones. Urology 2021; 154: 96–102 [DOI] [PubMed] [Google Scholar]
  • 136. Grosso AA, Sessa F, Campi R et al. Intraoperative and postoperative surgical complications after ureteroscopy, retrograde intrarenal surgery, and percutaneous nephrolithotomy: a systematic review. Minerva Urol Nephrol 2021; 73: 309–32 [DOI] [PubMed] [Google Scholar]
  • 137. Ozden C, Oztekin CV, Pasali S et al. Analysis of clinical factors associated with intraoperative and postoperative complications of retrograde intrarenal surgery. J Pak Med Assoc 2021; 71: 1666–70 [DOI] [PubMed] [Google Scholar]
  • 138. Akilov FA, Giyasov SI, Mukhtarov ST, Nasirov FR, Alidjanov JF. Applicability of the Clavien‐Dindo grading system for assessing the postoperative complications of endoscopic surgery for nephrolithiasis: a critical review. Turk J Urol 2013; 39: 153–60 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139. Xu Y, Min Z, Wan SP, Nie H, Duan G. Complications of retrograde intrarenal surgery classified by the modified Clavien grading system. Urolithiasis 2018; 46: 197–202 [DOI] [PubMed] [Google Scholar]
  • 140. Ibrahim AK. Reporting ureteroscopy complications using the modified clavien classification system. Urol Ann 2015; 7: 53–7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141. Kramolowsky EV. Ureteral perforation during ureterorenoscopy: treatment and management. J Urol 1987; 138: 36–8 [DOI] [PubMed] [Google Scholar]
  • 142. Silva Simões Estrela JR, Azevedo Ziomkowski A, Dauster B, Costa Matos A. Arteriocaliceal fistula: a life‐threatening condition after retrograde intrarenal surgery. J Endourol Case Rep 2020; 6: 241–3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143. Choi T, Choi J, Min GE, Lee DG. Massive retroperitoneal hematoma as an acute complication of retrograde intrarenal surgery: a case report. World J Clin Cases 2021; 9: 3914–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144. Cindolo L, Castellan P, Scoffone CM et al. Mortality and flexible ureteroscopy: analysis of six cases. World J Urol 2016; 34: 305–10 [DOI] [PubMed] [Google Scholar]
  • 145. Xu L, Li G. Life‐threatening subcapsular renal hematoma after flexible ureteroscopic laser lithotripsy: treatment with superselective renal arterial embolization. Urolithiasis 2013; 41: 449–51 [DOI] [PubMed] [Google Scholar]
  • 146. Peng L, Xu Z, Wen J, Zhong W, Zeng G. A quick stone component analysis matters in postoperative fever: a propensity score matching study of 1493 retrograde intrarenal surgery. World J Urol 2021; 39: 1277–85 [DOI] [PubMed] [Google Scholar]
  • 147. Pietropaolo A, Geraghty RM, Veeratterapillay R et al. A machine learning predictive model for post‐ureteroscopy urosepsis needing intensive care unit admission: a case‐control YAU endourology study from nine European Centres. J Clin Med 2021; 10: 3888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148. Chugh S, Pietropaolo A, Montanari E, Sarica K, Somani BK. Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU section of urolithiasis (EULIS). Curr Urol Rep 2020; 21: 16 [DOI] [PubMed] [Google Scholar]
  • 149. Zhong W, Zeng G, Wu K, Li X, Chen W, Yang H. Does a smaller tract in percutaneous nephrolithotomy contribute to high intrarenal pressure and postoperative fever? J Endourol 2008; 22: 2147–51 [DOI] [PubMed] [Google Scholar]
  • 150. Li T, Sun XZ, Lai DH, Li X, He YZ. Fever and systemic inflammatory response syndrome after retrograde intrarenal surgery: risk factors and predictive model. Kaohsiung J Med Sci 2018; 34: 400–8 [DOI] [PubMed] [Google Scholar]
  • 151. Fan J, Wan S, Liu L et al. Predictors for uroseptic shock in patients who undergo minimally invasive percutaneous nephrolithotomy. Urolithiasis 2017; 45: 573–8 [DOI] [PubMed] [Google Scholar]
  • 152. Wu H, Wang Z, Zhu S et al. Uroseptic shock can be reversed by early intervention based on leukocyte count 2h post‐operation: animal model and multicenter clinical cohort study. Inflammation 2018; 41: 1835–41 [DOI] [PubMed] [Google Scholar]
  • 153. Bonkat G, Cai T, Veeratterapillay R et al. Management of urosepsis in 2018. Eur Urol Focus 2019; 5: 5–9 [DOI] [PubMed] [Google Scholar]
  • 154. Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA 2016; 315: 801–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155. Somani BK, Giusti G, Sun Y et al. Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the clinical research Office of Endourological Society URS global study. World J Urol 2017; 35: 675–81 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156. Schoenthaler M, Buchholz N, Farin E et al. The post‐Ureteroscopic lesion scale (PULS): a multicenter video‐based evaluation of inter‐rater reliability. World J Urol 2014; 32: 1033–40 [DOI] [PubMed] [Google Scholar]
  • 157. Xiong S, Zhu W, Li X, Zhang P, Wang H, Li X. Intestinal interposition for complex ureteral reconstruction: a comprehensive review. Int J Urol 2020; 27: 377–86 [DOI] [PubMed] [Google Scholar]

Articles from Bju International are provided here courtesy of Wiley

RESOURCES